Search Results - "Karakulak, U."

Alterations of cardiometabolic risk profile in polycystic ovary syndrome: 13 years follow-up in an unselected population by Aksun, S., Sonu, N. C., Aygun, S., Karakulak, U. N., Mumusoglu, S., Yildiz, B. O.

“…Purpose Cardiometabolic risk factors are common in women with polycystic ovary syndrome (PCOS) during reproductive years. The aim of this study was to…”
Get full text

Evaluation of aortic elasticity parameters in arsenic exposed workers by Karakulak, U N, Yilmaz, O H, Tutkun, E, Aladag, E, Evranos, B, Bal, C, Gunduzoz, M, Ayturk, M, Ozturk, M T

“…One of the major complications of arsenic on human health is hypertension. Arsenic-related hypertension and negative effects of arsenic on arterial system such…”
Get full text

OP-093 PREDICTIVE VALUE OF FRAGMENTED QRS IN NONISCHEMIC DILATED CARDIOMYOPATHY PATIENTS WHO RECEIVE IMPLANTABLE CARDIOVERTER DEFIBRILLATORS FOR PRIMARY PREVENTION by Demiri, E, Kabakçı, G, Taher, A, Ülgen, A, Karakulak, U, Kaya, E.B, Şahiner, L, Yorgun, H, Aytemir, K, Oto, A

Get full text

OP-182 PERCUTANEOUS BALLOON MITRAL VALVULOPLASTY IN PREGNANCY: A SINGLE CENTER EXPERIENCE by Oto, A, Aytemir, K, Sunman, H, Arabi, P, Canpolat, U, Dural, M, Karakulak, U, Yorgun, H, Şahiner, L, Kaya, E.B, Tokgözoglu, L, Kabakçı, G

Get full text

Visualization of dual coronary artery fistulae drainage to the right ventricle by transthoracic echocardiography by Okutucu, S., Karakulak, U.N., Jam, F., Kaya, E.B., Aytemir, K., Oto, A.

“…Coronary artery fistula is a rare abnormality of coronary circulation. It is mostly congenital but acquired forms can also occur. Fistulae are usually…”
Get full text

OP-228: PREVALENCE AND PREDICTORS OF RENAL ARTERY STENOSIS IN HYPERTENSIVE PATIENTS UNDERGOING ELECTIVE CORONARY ANGIOGRAPHY by Kabakci, G, Canpolat, U, Yorgun, H, Fatihoglu, G, Karakulak, U, Sunman, H, Yalcin, U, Sahiner, L, Kaya, E.B, Aytemir, K, Tokgozoglu, L, Oto, A

Get full text

PP-042: RECURRENT IMPLANTABLE CARDIOVERTER DEFIBRILLATOR SHOCKS BECAUSE OF TORSADES DE POINTES ASSOCIATED WITH CLARITHROMYCIN AND SOTALOL by Fatihoglu, S.G, Okutucu, S, Karakulak, U, Jam, F, Evranos, B, Sahiner, L, Kaya, E.B, Aytemir, K, Tokgozoglu, L, Kabakci, G, Ozkutlu, H, Oto, A

Get full text

Effects of mitral annular calcification on the outcomes of transcatheter aortic valve implantation by Sener, Y Z, Tokgozoglu, S L, Ardali, S, Karakulak, U N, Ates, A H, Sahiner, M L, Kaya, E B, Atalar, E, Ozer, N, Hazirolan, T, Aytemir, K

“…Abstract Background Transcatheter aortic valve implantation (TAVI) has become the standard of care treatment in patients with severe aortic stenosis who carry…”
Get full text

Ganglionated plexi ablation during cryoballoon ablation prevents recurrence of atrial fibrillation by Aytemir, K., Yorgun, H., Canpolat, U., Sunman, H., Karakulak, U., Sahiner, L., Kaya, B., Tokgozoglu, L., Kabakci, G., Oto, A.

Get full text

Cardiac resynchronization therapy improves exercise heart rate recovery in patients with heart failure by Okutucu, Sercan, Aytemir, Kudret, Evranos, Banu, Aksoy, Hakan, Sabanov, Cingiz, Karakulak, Ugur Nadir, Kaya, Ergun Baris, Kabakci, Giray, Tokgozoglu, Lale, Ozkutlu, Hilmi, Oto, Ali

“…Heart rate (HR) recovery (HRR), defined as the rate of decline in the HR immediately following the cessation of exercise, is influenced by autonomic function…”
Get full text

Poster session 5: Friday 5 December 2014, 14:00-18:00 Location: Poster area by Turco, A., Duchenne, J., Nuyts, J., Gheysens, O., Voigt, J.-U., Claus, P., Vunckx, K., Muhtarov, K., Ozer, N., Turk, G., Sunman, H., Karakulak, U., Sahiner, L., Kaya, B., Yorgun, H., Hazirolan, T., Aytemir, K., Warita, S., Kawasaki, M., Tanaka, R., Houle, H., Yagasaki, H., Nagaya, M., Ono, K., Noda, T., Watanabe, S., Minatoguchi, S., Kyle, A., Dauphin, C., Lusson, J. R., Dragoi Galrinho, R., Rimbas, R., Ciobanu, A., Marinescu, B., Cinteza, M., Vinereanu, D., Aparina, O., Stukalova, O., Butorova, E., Makeev, M., Bolotova, M., Parkhomenko, D., Golitsyn, S., Zengin, E., Hoffmann, B. A., Ramuschkat, M., Ojeda, F., Weiss, C., Willems, S., Blankenberg, S., Schnabel, R. B., Sinning, C. R., Schubert, U., Suhai, F. I., Toth, A., Kecskes, K., Czimbalmos, C., Csecs, I., Maurovich-Horvat, P., Simor, T., Merkely, B., Vago, H., Slawek, D., Chrzanowski, L., Krecki, R., Binkowska, A., Kasprzak, J. D., Palombo, C., Morizzo, C., Kozakova, M., Charisopoulou, D., Koulaouzidis, G., Rydberg, A., Henein, M., Kovacs, A., Olah, A., Lux, A., Matyas, C., Nemeth, B., Kellermayer, D., Ruppert, M., Birtalan, E., Radovits, T., Henri, C., Dulgheru, R., Magne, J., Kou, S., Davin, L., Nchimi, A., Oury, C., Pierard, L., Lancellotti, P., Sahin, S. T., Cengiz, B., Yurdakul, S., Altuntas, E., Aytekin, V., Aytekin, S., Bajraktari, G., Ibrahimi, P.

Get full text

The prediction of atrial fibrillation development in patients treated with transcatheter aortic valve implantation by Karakulak, UN, Sahiner, ML, Sener, YZ, Kaya, EB, Aytemir, K

“…Abstract Funding Acknowledgements Type of funding sources: None. Backround Atrial fibrillation (AF) is associated with poor outcomes after transcatheter aortic…”
Get full text

OP-069 Evaluation of Effectiveness and Safety of Everolimus Eluting Stent System (XIENCE V) in the Treatment of Coronary Artery Lesions by Karakulak, U.N, Yorgun, H, Şahiner, L, Kaya, B, Kabakçı, G, Aytemir, K, Oto, A

“…The population in the previous drug eluting stent studies has very risk profile and therefore not reflects real-world information. [...]there are limited data…”
Get full text

OP-008 Evaluation of Effectiveness and Safety of Everolimus Eluting Stent System (XIENCE V) in Patients with Atrial Fibrillation by Karakulak, U.N, Yorgun, H, Şahiner, L, Kaya, B, Kabakçı, G, Aytemir, K, Oto, A

“…For all outcomes, there are no significant differences between patients with AF and sinus rhythm. [...]procedure related complication rate was same between the…”
Get full text

OP-007 Evaluation Of Effectiveness And Safety Of Everolimus Eluting Stent System (XIENCE V) In Acute Coronary Syndrome Patients by Karakulak, U.N, Yorgun, H, Şahiner, L, Kaya, B, Kabakçı, G, Aytemir, K, Oto, A

“…In this study, everolimus eluting stent (XIENCE V) implantations and follow up results in patients presented with ACS were evaluated. 126 ACS patients who…”
Get full text